Cargando…
IgY antibodies against Ebola virus possess post-exposure protection in a murine pseudovirus challenge model and excellent thermostability
Ebola virus (EBOV) is one of the most virulent pathogens that causes hemorrhagic fever and displays high mortality rates and low prognosis rates in both humans and nonhuman primates. The post-exposure antibody therapies to prevent EBOV infection are considered effective as of yet. However, owing to...
Autores principales: | Zhang, Yuan, Wei, Yanqiu, Li, Yunlong, Wang, Xuan, Liu, Yang, Tian, Deyu, Jia, Xiaojuan, Gong, Rui, Liu, Wenjun, Yang, Limin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7990235/ https://www.ncbi.nlm.nih.gov/pubmed/33711011 http://dx.doi.org/10.1371/journal.pntd.0008403 |
Ejemplares similares
-
Antigen-binding affinity and thermostability of chimeric mouse-chicken IgY and mouse-human IgG antibodies with identical variable domains
por: Choi, Juho, et al.
Publicado: (2019) -
Teicoplanin inhibits Ebola pseudovirus infection in cell culture
por: Wang, Yizhuo, et al.
Publicado: (2016) -
IgY Antibodies as Biotherapeutics in Biomedicine
por: León-Núñez, Diana, et al.
Publicado: (2022) -
IgY‐binding peptide screened from a random peptide library as a ligand for IgY purification
por: Khan, Kamrul Hasan, et al.
Publicado: (2017) -
Trends in industrialization and commercialization of IgY technology
por: Yakhkeshi, Saeed, et al.
Publicado: (2022)